Showing results (151-160 of 1,794) with videos related to

Sort By:
Pageof 180
Mabs|February 14, 2012
Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological functionHongcheng Liu, Kimberly May
Mabs|February 14, 2012
A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targetingIngo Schubert, Christian Kellner, Christoph Stein, et al.
Mabs|February 14, 2012
Analytical characterization of ch14.18: a mouse-human chimeric disialoganglioside-specific therapeutic antibodyGopalan Soman, Abraham T Kallarakal, Dennis Michiel, et al.
Mabs|February 14, 2012
Subcutaneous bioavailability of therapeutic antibodies as a function of FcRn binding affinity in miceRong Deng, Y Gloria Meng, Kwame Hoyte, et al.
Mabs|February 14, 2012
New developments in malaria diagnostics: monoclonal antibodies against Plasmodium dihydrofolate reductase-thymidylate synthase, heme detoxification protein and glutamate rich proteinJohanna H Kattenberg, Inge Versteeg, Stephanie J Migchelsen, et al.
Mabs|November 21, 2013
Fine epitope specificity of antibodies against interleukin-2 explains their paradoxical immunomodulatory effectsGertrudis Rojas, Yanelys Cabrera Infante, Amaury Pupo, et al.
Mabs|December 20, 2019
Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studiesChunze Li, Cindy Zhang, Zao Li, et al.
Mabs|March 7, 2020
Analytical characterization of coformulated antibodies as combination therapyJun Kim, Yoen Joo Kim, Mingyan Cao, et al.
Mabs|February 29, 2020
HX008: a humanized PD-1 blocking antibody with potent antitumor activity and superior pharmacologic propertiesJibin Zhang, Ying Huang, Gan Xi, et al.
Mabs|December 5, 2019
An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific bindingGuangcan Cao, Xinyu Gao, Yancheng Zhan, et al.
Pageof 180